Re: Tetrasilver Tetroxide (TST) TEST DATA Marantech.com

TEST DATA

To date, most of the Company’s testing of compounds for pharmacological safety and efficacy has centered on Tetrasilver Tetroxide (TST). Several of the largest contract research organizations in the world (Quintiles, Parexel, MDS/Pharma and others) have conducted laboratory evaluation of the compound and provided independent assessment of its performance potential.

Efficacy and non-toxicity has been assessed through initial in-vitro and clinical testing.

Results of in-vitro tests commissioned by Marantech strongly suggest that TST molecules selectively target and kill rapidly proliferating bacteria, viruses, fungi, protozoa, and cancer cells. Specifically, the tests showed that a very wide spectrum of gram-negative and gram-positive bacteria was destroyed, including several of the leading antibiotic-resistant bacteria, viruses, protozoa and fungi in concentrations ranging between 0.50 and 96.00 parts-per-million. Independent testing has also indicated the compound’s ability to inhibit the production of a wide range of cancer cells.

http://www.marantech.com/testdata.htm

Tweet